Structure-based virtual screening and characterization of a novel IL-6 antagonistic compound from synthetic compound database

References

• BoulangerMJChowDCBrevnovaEEGarciaKCHexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complexScience200330056282101210412829785
   PubMed Web of Science ®Google Scholar
• MatsudaTYamasakiKTagaTHiranoTKishimotoTCurrent concepts of B cell modulationInt Rev Immunol198952971098691054
   PubMedGoogle Scholar
• EavesCJCashmanJDKayRJMechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layerBlood19917811101171712638
   PubMed Web of Science ®Google Scholar
• DowtonSBWaggonerDJMandlKDDevelopmental regulation of expression of C-reactive protein and serum amyloid A in Syrian hamstersPediatr Res19913054444491754300
   PubMed Web of Science ®Google Scholar
• HideshimaTBergsagelPLKuehlWMAndersonKCAdvances in biology of multiple myeloma: clinical applicationsBlood2004104360761815090448
   PubMed Web of Science ®Google Scholar
• NishimotoNKanakuraYAozasaKHumanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman diseaseBlood200510682627263215998837
   PubMed Web of Science ®Google Scholar
• SmolenJSSteinerGAringerMAnti-cytokine therapy in systemic lupus erythematosusLupus200514318919115807194
   PubMed Web of Science ®Google Scholar
• TakagiNMiharaMMoriyaYBlockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritisArthritis Rheum19984112211721219870868
   PubMed Web of Science ®Google Scholar
• SchweitzerDHBoxmanILLowikCWParathyroid hormone related protein and interleukin-6 mRNA expression in larynx and renal cell carcinomas from normocalcaemic and hypercalcaemic patientsJ Clin Pathol199548108969008537484
   PubMed Web of Science ®Google Scholar
• YamasakiKTagaTHirataYCloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptorScience198824148678258283136546
   PubMed Web of Science ®Google Scholar
• SomersWStahlMSeehraJS1.9 A crystal structure of interleukin 6: implications for a novel mode of receptor dimerization and signalingEMBO J19971659899979118960
   PubMed Web of Science ®Google Scholar
• FontaineVSavinoRArconeRInvolvement of the Arg179 in the active site of human IL-6Eur J Biochem199321137497558436132
   PubMedGoogle Scholar
• van DamMMullbergJSchooltinkHStructure-function analysis of interleukin-6 utilizing human/murine chimeric molecules. Involvement of two separate domains in receptor bindingJ Biol Chem19932682015285152908325898
   PubMed Web of Science ®Google Scholar
• SavinoRLahmASalvatiALGeneration of interleukin-6 receptor antagonists by molecular-modeling guided mutagenesis of residues important for gp130 activationEMBO J1994136135713677511100
   PubMed Web of Science ®Google Scholar
• PaonessaGGrazianiRDe SerioATwo distinct and independent sites on IL-6 trigger gp 130 dimer formation and signallingEMBO J1995149194219517744001
   PubMed Web of Science ®Google Scholar
• EhlersMde HonFDBosHKCombining two mutations of human interleukin-6 that affect gp130 activation results in a potent interleukin-6 receptor antagonist on human myeloma cellsJ Biol Chem199527014815881637713920
   PubMed Web of Science ®Google Scholar
• EhlersMGrotzingerJFischerMBosHKBrakenhoffJPRose-JohnSIdentification of single amino acid residues of human IL-6 involved in receptor binding and signal initiationJ Interferon Cytokine Res19961685695768877726
   PubMed Web of Science ®Google Scholar
• GrotzingerJKurapkatGWollmerAKalaiMRose-JohnSThe family of the IL-6-type cytokines: specificity and promiscuity of the receptor complexesProteins1997271961099037715
   PubMed Web of Science ®Google Scholar
• VollmerPOppmannBVoltzNFischerMRose-JohnSA role for the immunoglobulin-like domain of the human IL-6 receptor. Intracellular protein transport and sheddingEur J Biochem1999263243844610406952
   PubMedGoogle Scholar
• BazanJFStructural design and molecular evolution of a cytokine receptor superfamilyProc Natl Acad Sci U S A19908718693469382169613
   PubMed Web of Science ®Google Scholar
• VargheseJNMoritzRLLouMZStructure of the extracellular domains of the human interleukin-6 receptor α -chainProc Natl Acad Sci U S A20029925159591596412461182
   PubMed Web of Science ®Google Scholar
• ColeARHallNETreutleinHRDisulfide bond structure and N-glycosylation sites of the extracellular domain of the human interleukin-6 receptorJ Biol Chem1999274117207721510066782
   PubMed Web of Science ®Google Scholar
• TagaTKishimotoTGp130 and the interleukin-6 family of cytokinesAnnu Rev Immunol1997157978199143707
   PubMed Web of Science ®Google Scholar
• ChowDHeXSnowALRose-JohnSGarciaKCStructure of an extracellular gp130 cytokine receptor signaling complexScience200129155112150215511251120
   PubMed Web of Science ®Google Scholar
• FengJLiYShenBThe design of antagonist peptide of hIL-6 based on the binding epitope of hIL-6 by computer-aided molecular modelingPeptides20042571123113115245871
   PubMed Web of Science ®Google Scholar
• YangZFengJHuMA novel hIL-6 antagonist peptide from computer-aided design contributes to suppression of apoptosis in M1 cellsBiochem Biophys Res Commun2004325251852415530423
   PubMed Web of Science ®Google Scholar
• YangZFengJLiYStructure-based design and characterization of a Novel IL-6 antagonist peptideMol Immunol20054291015102115829291
   PubMed Web of Science ®Google Scholar
• FengJYangZLiYThe rational designed antagonist derived from the complex structure of interleukin-6 and its receptor affectively blocking interleukin-6 might be a promising treatment in multiple myelomaBiochimie20068891265127316626851
   PubMed Web of Science ®Google Scholar
• FerrariSMorandiFMotiejunasDVirtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductaseJ Med Chem201054121122121126022
   PubMed Web of Science ®Google Scholar
• CummingsMDSchubertCParksDJSubstituted 1,4- benzodiazepine-2,5-diones as alpha-helix mimetic antagonists of the HDM2-p53 protein-protein interactionChem Biol Drug Des200667320120516611213
   PubMed Web of Science ®Google Scholar
• ZhangXGGaillardJPRobillardNReproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myelomaBlood19948312365436638204890
   PubMed Web of Science ®Google Scholar
• SongLLiYSunYShenBMcl-1 mediates cytokine deprivation induced apoptosis of human myeloma cell line XG-7Chin Med J (Engl)200211581241124312215301
   PubMed Web of Science ®Google Scholar
• ManfrediniRTenediniESienaMDevelopment of an IL-6 antagonist peptide that induces apoptosis in 7TD1 cellsPeptides20032481207122014612193
   PubMed Web of Science ®Google Scholar
• RissTLMoravecRANilesALCell viability assaysSittampalamGSCoussensNPNelsonHAssay Guidance ManualBethesda, MDEli Lilly & Company2004130
   Google Scholar
• HitzlerJKMartinez-ValdezHBergsagelDBMindenMDMessnerHARole of interleukin-6 in the proliferation of human multiple myeloma cell lines OCI-My 1 to 7 established from patients with advanced stage of the diseaseBlood1991788199620041912582
   PubMed Web of Science ®Google Scholar
• KurthIHorstenUPflanzSActivation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopesJ Immunol19991623148014879973404
   PubMed Web of Science ®Google Scholar
• GrinterSZZouXChallenges, applications, and recent advances of protein-ligand docking in structure-based drug designMolecules2014197101501017625019558
   PubMed Web of Science ®Google Scholar